Stay updated on Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial
Sign up to get notified when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.

Latest updates to the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page
- Check5 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page previously displaying a study record now shows a 403 Forbidden error, with site chrome (navigation/footer) still visible, indicating the content is temporarily inaccessible.SummaryDifference19%

- Check47 days agoChange DetectedA new NIH grant/contract identifier was added to the study's identifiers, and the page revision was updated to v3.6.6.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, reflecting a minor platform update rather than changes to user-facing content.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision: v3.6.4 is now shown in the page footer, replacing the previous v3.6.3. This reflects a minor version update to the site's interface rather than changes to the study data.SummaryDifference0.0%

- Check104 days agoChange DetectedThe website now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2, indicating an update to the page's revision identifier rather than to study data or content.SummaryDifference0.0%

Stay in the know with updates to Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.